Innate Pharma S.A. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
IPHA Nasdaq 2836 www.innate-pharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Innate Pharma S.A.

Number of Shares and Voting Rights of Innate Pharma as of December 31, 2025 - Jan 6th, 2026 11:00 pm
Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025 - Dec 21st, 2025 11:00 pm
Innate Pharma Releases Its 2026 Financial Calendar - Dec 10th, 2025 11:00 pm
Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025 - Nov 27th, 2025 11:00 pm
Mycosis Fungoides Market Set to Expand by 2034 with Advancements in Targeted and Immunotherapy Approaches | DelveInsight - Nov 26th, 2025 3:31 pm
Innate Pharma to Present at Jefferies Global Healthcare Conference - Nov 16th, 2025 11:00 pm
Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results - Nov 12th, 2025 11:00 pm
Innate Pharma Receives US FDA Clearance to Begin Phase 3 Trial of Potential Skin Cancer Therapy - Nov 10th, 2025 2:45 am
Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL - Nov 9th, 2025 11:00 pm
Innate Pharma (IPHA) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - Nov 6th, 2025 7:55 am
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates - Nov 4th, 2025 11:00 pm
Innate Pharma to Host Analyst and Investor Event on Lacutamab on October 28, 2025 - Oct 13th, 2025 11:00 pm
How the Narrative Around Innate Pharma Is Shifting After Recent Strategic Decisions - Sep 20th, 2025 6:21 am
Target initiated, Nike upgraded: Wall Street's top analyst calls - Sep 18th, 2025 7:38 am
Innate Pharma SA (IPHA) (H1 2025) Earnings Call Highlights: Strategic Focus and Financial ... - Sep 18th, 2025 1:00 am
Innate Pharma Reports First Half 2025 Business Update and Financial Results - Sep 16th, 2025 11:00 pm
Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event - Sep 14th, 2025 11:00 pm
Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update - Sep 10th, 2025 2:30 am
Number of Shares and Voting Rights of Innate Pharma as of September 1, 2025 - Sep 1st, 2025 11:00 pm
Tetraspecific Antibodies Market Research 2025-2029 | Molecular Partners, Innate Pharma, and ModeX Therapeutics Lead Innovations for Oncology and Autoimmune - Aug 6th, 2025 2:24 am